Global Radiopharmaceuticals Market Growth 2021-2026
According to this latest study, the 2021 growth of Radiopharmaceuticals will have significant change from previous year. By the most conservative estimates of global Radiopharmaceuticals market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 6123.9 million in 2020. Over the next five years the Radiopharmaceuticals market will register a 8.3% CAGR in terms of revenue, the global market size will reach US$ 8424.2 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Diagnostic Radioisotopes
Therapeutic Radioisotopes
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Oncology
Cardiology
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Radiopharmaceuticals Consumption 2016-2026
2.1.2 Radiopharmaceuticals Consumption CAGR by Region
2.2 Radiopharmaceuticals Segment by Type
2.2.1 Diagnostic Radioisotopes
2.2.2 Therapeutic Radioisotopes
2.3 Radiopharmaceuticals Sales by Type
2.3.1 Global Radiopharmaceuticals Sales Market Share by Type (2016-2021)
2.3.2 Global Radiopharmaceuticals Revenue and Market Share by Type (2016-2021)
2.3.3 Global Radiopharmaceuticals Sale Price by Type (2016-2021)
2.4 Radiopharmaceuticals Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Radiopharmaceuticals Sales by Application
2.5.1 Global Radiopharmaceuticals Sale Market Share by Application (2016-2021)
2.5.2 Global Radiopharmaceuticals Revenue and Market Share by Application (2016-2021)
2.5.3 Global Radiopharmaceuticals Sale Price by Application (2016-2021)
3 Global Radiopharmaceuticals by Company
3.1 Global Radiopharmaceuticals Sales Market Share by Company
3.1.1 Global Radiopharmaceuticals Sales by Company (2019-2021)
3.1.2 Global Radiopharmaceuticals Sales Market Share by Company (2019-2021)
3.2 Global Radiopharmaceuticals Revenue Market Share by Company
3.2.1 Global Radiopharmaceuticals Revenue by Company (2019-2021)
3.2.2 Global Radiopharmaceuticals Revenue Market Share by Company (2019-2021)
3.3 Global Radiopharmaceuticals Sale Price by Company
3.4 Global Manufacturers Radiopharmaceuticals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Radiopharmaceuticals Product Location Distribution
3.4.2 Players Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Radiopharmaceuticals by Region
4.1 Global Radiopharmaceuticals by Region
4.1.1 Global Radiopharmaceuticals Sales by Region
4.1.2 Global Radiopharmaceuticals Revenue by Region
4.2 Americas Radiopharmaceuticals Sales Growth
4.3 APAC Radiopharmaceuticals Sales Growth
4.4 Europe Radiopharmaceuticals Sales Growth
4.5 Middle East & Africa Radiopharmaceuticals Sales Growth
5 Americas
5.1 Americas Radiopharmaceuticals Sales by Country
5.1.1 Americas Radiopharmaceuticals Sales by Country (2016-2021)
5.1.2 Americas Radiopharmaceuticals Revenue by Country (2016-2021)
5.2 Americas Radiopharmaceuticals Sales by Type
5.3 Americas Radiopharmaceuticals Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiopharmaceuticals Sales by Region
6.1.1 APAC Radiopharmaceuticals Sales by Region (2016-2021)
6.1.2 APAC Radiopharmaceuticals Revenue by Region (2016-2021)
6.2 APAC Radiopharmaceuticals Sales by Type
6.3 APAC Radiopharmaceuticals Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Radiopharmaceuticals by Country
7.1.1 Europe Radiopharmaceuticals Sales by Country (2016-2021)
7.1.2 Europe Radiopharmaceuticals Revenue by Country (2016-2021)
7.2 Europe Radiopharmaceuticals Sales by Type
7.3 Europe Radiopharmaceuticals Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Radiopharmaceuticals by Country
8.1.1 Middle East & Africa Radiopharmaceuticals Sales by Country (2016-2021)
8.1.2 Middle East & Africa Radiopharmaceuticals Revenue by Country (2016-2021)
8.2 Middle East & Africa Radiopharmaceuticals Sales by Type
8.3 Middle East & Africa Radiopharmaceuticals Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Radiopharmaceuticals Distributors
10.3 Radiopharmaceuticals Customer
11 Global Radiopharmaceuticals Market Forecast
11.1 Global Radiopharmaceuticals Forecast by Region
11.1.1 Global Radiopharmaceuticals Forecast by Regions (2021-2026)
11.2.2 Global Radiopharmaceuticals Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Radiopharmaceuticals Forecast by Type
11.7 Global Radiopharmaceuticals Forecast by Application
12 Key Players Analysis
12.1 Bracco Imaging
12.1.1 Bracco Imaging Company Information
12.1.2 Bracco Imaging Radiopharmaceuticals Product Offered
12.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Bracco Imaging Main Business Overview
12.1.5 Bracco Imaging Latest Developments
12.2 Bayer
12.2.1 Bayer Company Information
12.2.2 Bayer Radiopharmaceuticals Product Offered
12.2.3 Bayer Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Bayer Main Business Overview
12.2.5 Bayer Latest Developments
12.3 Mallinckrodt
12.3.1 Mallinckrodt Company Information
12.3.2 Mallinckrodt Radiopharmaceuticals Product Offered
12.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Mallinckrodt Main Business Overview
12.3.5 Mallinckrodt Latest Developments
12.4 Nordion
12.4.1 Nordion Company Information
12.4.2 Nordion Radiopharmaceuticals Product Offered
12.4.3 Nordion Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Nordion Main Business Overview
12.4.5 Nordion Latest Developments
12.5 Triad Isotopes
12.5.1 Triad Isotopes Company Information
12.5.2 Triad Isotopes Radiopharmaceuticals Product Offered
12.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Triad Isotopes Main Business Overview
12.5.5 Triad Isotopes Latest Developments
12.6 Lantheus
12.6.1 Lantheus Company Information
12.6.2 Lantheus Radiopharmaceuticals Product Offered
12.6.3 Lantheus Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Lantheus Main Business Overview
12.6.5 Lantheus Latest Developments
12.7 IBA Group
12.7.1 IBA Group Company Information
12.7.2 IBA Group Radiopharmaceuticals Product Offered
12.7.3 IBA Group Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 IBA Group Main Business Overview
12.7.5 IBA Group Latest Developments
12.8 GE Healthcare
12.8.1 GE Healthcare Company Information
12.8.2 GE Healthcare Radiopharmaceuticals Product Offered
12.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 GE Healthcare Main Business Overview
12.8.5 GE Healthcare Latest Developments
12.9 China Isotope & Radiation
12.9.1 China Isotope & Radiation Company Information
12.9.2 China Isotope & Radiation Radiopharmaceuticals Product Offered
12.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 China Isotope & Radiation Main Business Overview
12.9.5 China Isotope & Radiation Latest Developments
12.10 Jubilant Pharma
12.10.1 Jubilant Pharma Company Information
12.10.2 Jubilant Pharma Radiopharmaceuticals Product Offered
12.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Jubilant Pharma Main Business Overview
12.10.5 Jubilant Pharma Latest Developments
12.11 Eli Lilly
12.11.1 Eli Lilly Company Information
12.11.2 Eli Lilly Radiopharmaceuticals Product Offered
12.11.3 Eli Lilly Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Eli Lilly Main Business Overview
12.11.5 Eli Lilly Latest Developments
12.12 Advanced Accelerator Applications
12.12.1 Advanced Accelerator Applications Company Information
12.12.2 Advanced Accelerator Applications Radiopharmaceuticals Product Offered
12.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Advanced Accelerator Applications Main Business Overview
12.12.5 Advanced Accelerator Applications Latest Developments
12.13 SIEMENS
12.13.1 SIEMENS Company Information
12.13.2 SIEMENS Radiopharmaceuticals Product Offered
12.13.3 SIEMENS Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 SIEMENS Main Business Overview
12.13.5 SIEMENS Latest Developments
12.14 Dongcheng
12.14.1 Dongcheng Company Information
12.14.2 Dongcheng Radiopharmaceuticals Product Offered
12.14.3 Dongcheng Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Dongcheng Main Business Overview
12.14.5 Dongcheng Latest Developments
12.15 Navidea
12.15.1 Navidea Company Information
12.15.2 Navidea Radiopharmaceuticals Product Offered
12.15.3 Navidea Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Navidea Main Business Overview
12.15.5 Navidea Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Radiopharmaceuticals Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Diagnostic Radioisotopes
Table 3. Major Players of Therapeutic Radioisotopes
Table 4. Global Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
Table 5. Global Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 6. Global Radiopharmaceuticals Revenue by Type (2016-2021) & ($ million)
Table 7. Global Radiopharmaceuticals Revenue Market Share by Type (2016-2021)
Table 8. Global Radiopharmaceuticals Sale Price by Type (2016-2021)
Table 9. Global Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
Table 10. Global Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 11. Global Radiopharmaceuticals Value by Application (2016-2021)
Table 12. Global Radiopharmaceuticals Revenue Market Share by Application (2016-2021)
Table 13. Global Radiopharmaceuticals Sale Price by Application (2016-2021)
Table 14. Global Radiopharmaceuticals Sales by Company (2019-2021) & (K Dose)
Table 15. Global Radiopharmaceuticals Sales Market Share by Company (2019-2021)
Table 16. Global Radiopharmaceuticals Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Radiopharmaceuticals Revenue Market Share by Company (2019-2021)
Table 18. Global Radiopharmaceuticals Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Radiopharmaceuticals Producing Area Distribution and Sales Area
Table 20. Players Radiopharmaceuticals Products Offered
Table 21. Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Radiopharmaceuticals Sales by Region (2016-2021) (K Dose)
Table 25. Global Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Table 26. Global Radiopharmaceuticals Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Table 28. Americas Radiopharmaceuticals Sales by Country (2016-2021) & (K Dose)
Table 29. Americas Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 30. Americas Radiopharmaceuticals Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 32. Americas Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
Table 33. Americas Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 34. Americas Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
Table 35. Americas Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 36. APAC Radiopharmaceuticals Sales by Region (2016-2021) & (K Dose)
Table 37. APAC Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Table 38. APAC Radiopharmaceuticals Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Table 40. APAC Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
Table 41. APAC Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 42. APAC Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
Table 43. APAC Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 44. Europe Radiopharmaceuticals Sales by Country (2016-2021) & (K Dose)
Table 45. Europe Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 46. Europe Radiopharmaceuticals Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 48. Europe Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
Table 49. Europe Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 50. Europe Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
Table 51. Europe Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Radiopharmaceuticals Sales by Country (2016-2021) & (K Dose)
Table 53. Middle East & Africa Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Radiopharmaceuticals Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
Table 57. Middle East & Africa Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
Table 59. Middle East & Africa Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Radiopharmaceuticals
Table 61. Key Application and Potential Industries of Radiopharmaceuticals
Table 62. Key Challenges of Radiopharmaceuticals
Table 63. Key Trends of Radiopharmaceuticals
Table 64. Radiopharmaceuticals Distributors List
Table 65. Radiopharmaceuticals Customer List
Table 66. Global Radiopharmaceuticals Sales Forecast by Region (2021-2026) & (K Dose)
Table 67. Global Radiopharmaceuticals Consumption Market Forecast by Region
Table 68. Global Radiopharmaceuticals Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Radiopharmaceuticals Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Radiopharmaceuticals Sales Forecast by Country (2021-2026) & (K Dose)
Table 71. Americas Radiopharmaceuticals Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Radiopharmaceuticals Sales Forecast by Region (2021-2026) & (K Dose)
Table 73. APAC Radiopharmaceuticals Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Radiopharmaceuticals Sales Forecast by Country (2021-2026) & (K Dose)
Table 75. Europe Radiopharmaceuticals Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Radiopharmaceuticals Sales Forecast by Country (2021-2026) & (K Dose)
Table 77. Middle East & Africa Radiopharmaceuticals Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Radiopharmaceuticals Sales Forecast by Type (2021-2026) & (K Dose)
Table 79. Global Radiopharmaceuticals Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Radiopharmaceuticals Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Radiopharmaceuticals Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Radiopharmaceuticals Sales Forecast by Application (2021-2026) & (K Dose)
Table 83. Global Radiopharmaceuticals Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Radiopharmaceuticals Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Radiopharmaceuticals Revenue Market Share Forecast by Application (2021-2026)
Table 86. Bracco Imaging Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 87. Bracco Imaging Radiopharmaceuticals Product Offered
Table 88. Bracco Imaging Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)
Table 89. Bracco Imaging Main Business
Table 90. Bracco Imaging Latest Developments
Table 91. Bayer Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 92. Bayer Radiopharmaceuticals Product Offered
Table 93. Bayer Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)
Table 94. Bayer Main Business
Table 95. Bayer Latest Developments
Table 96. Mallinckrodt Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 97. Mallinckrodt Radiopharmaceuticals Product Offered
Table 98. Mallinckrodt Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)
Table 99. Mallinckrodt Main Business
Table 100. Mallinckrodt Latest Developments
Table 101. Nordion Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 102. Nordion Radiopharmaceuticals Product Offered
Table 103. Nordion Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)
Table 104. Nordion Main Business
Table 105. Nordion Latest Developments
Table 106. Triad Isotopes Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 107. Triad Isotopes Radiopharmaceuticals Product Offered
Table 108. Triad Isotopes Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)
Table 109. Triad Isotopes Main Business
Table 110. Triad Isotopes Latest Developments
Table 111. Lantheus Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 112. Lantheus Radiopharmaceuticals Product Offered
Table 113. Lantheus Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)
Table 114. Lantheus Main Business
Table 115. Lantheus Latest Developments
Table 116. IBA Group Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 117. IBA Group Radiopharmaceuticals Product Offered
Table 118. IBA Group Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)
Table 119. IBA Group Main Business
Table 120. IBA Group Latest Developments
Table 121. GE Healthcare Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 122. GE Healthcare Radiopharmaceuticals Product Offered
Table 123. GE Healthcare Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)
Table 124. GE Healthcare Main Business
Table 125. GE Healthcare Latest Developments
Table 126. China Isotope & Radiation Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 127. China Isotope & Radiation Radiopharmaceuticals Product Offered
Table 128. China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)
Table 129. China Isotope & Radiation Main Business
Table 130. China Isotope & Radiation Latest Developments
Table 131. Jubilant Pharma Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 132. Jubilant Pharma Radiopharmaceuticals Product Offered
Table 133. Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)
Table 134. Jubilant Pharma Main Business
Table 135. Jubilant Pharma Latest Developments
Table 136. Eli Lilly Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 137. Eli Lilly Radiopharmaceuticals Product Offered
Table 138. Eli Lilly Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)
Table 139. Eli Lilly Main Business
Table 140. Eli Lilly Latest Developments
Table 141. Advanced Accelerator Applications Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 142. Advanced Accelerator Applications Radiopharmaceuticals Product Offered
Table 143. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)
Table 144. Advanced Accelerator Applications Main Business
Table 145. Advanced Accelerator Applications Latest Developments
Table 146. SIEMENS Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 147. SIEMENS Radiopharmaceuticals Product Offered
Table 148. SIEMENS Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)
Table 149. SIEMENS Main Business
Table 150. SIEMENS Latest Developments
Table 151. Dongcheng Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 152. Dongcheng Radiopharmaceuticals Product Offered
Table 153. Dongcheng Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)
Table 154. Dongcheng Main Business
Table 155. Dongcheng Latest Developments
Table 156. Navidea Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 157. Navidea Radiopharmaceuticals Product Offered
Table 158. Navidea Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)
Table 159. Navidea Main Business
Table 160. Navidea Latest Developments
List of Figures
Figure 1. Picture of Radiopharmaceuticals
Figure 2. Radiopharmaceuticals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Radiopharmaceuticals Sales Growth Rate 2016-2026 (K Dose)
Figure 7. Global Radiopharmaceuticals Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Radiopharmaceuticals Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Diagnostic Radioisotopes
Figure 10. Product Picture of Therapeutic Radioisotopes
Figure 11. Global Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 12. Global Radiopharmaceuticals Revenue Market Share by Type (2016-2021)
Figure 13. Radiopharmaceuticals Consumed in Oncology
Figure 14. Global Radiopharmaceuticals Market: Oncology (2016-2021) & (K Dose)
Figure 15. Radiopharmaceuticals Consumed in Cardiology
Figure 16. Global Radiopharmaceuticals Market: Cardiology (2016-2021) & (K Dose)
Figure 17. Radiopharmaceuticals Consumed in Other
Figure 18. Global Radiopharmaceuticals Market: Other (2016-2021) & (K Dose)
Figure 19. Global Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Figure 20. Global Radiopharmaceuticals Revenue Market Share by Application in 2020
Figure 21. Radiopharmaceuticals Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Radiopharmaceuticals Revenue Market Share by Company in 2020
Figure 23. Global Radiopharmaceuticals Sales Market Share by Regions (2016-2021)
Figure 24. Global Radiopharmaceuticals Revenue Market Share by Region in 2020
Figure 25. Americas Radiopharmaceuticals Sales 2016-2021 (K Dose)
Figure 26. Americas Radiopharmaceuticals Revenue 2016-2021 ($ Millions)
Figure 27. APAC Radiopharmaceuticals Sales 2016-2021 (K Dose)
Figure 28. APAC Radiopharmaceuticals Revenue 2016-2021 ($ Millions)
Figure 29. Europe Radiopharmaceuticals Sales 2016-2021 (K Dose)
Figure 30. Europe Radiopharmaceuticals Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Radiopharmaceuticals Sales 2016-2021 (K Dose)
Figure 32. Middle East & Africa Radiopharmaceuticals Revenue 2016-2021 ($ Millions)
Figure 33. Americas Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 34. Americas Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 35. Americas Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 36. Americas Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 37. United States Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Radiopharmaceuticals Sales Market Share by Region in 2020
Figure 42. APAC Radiopharmaceuticals Revenue Market Share by Regions in 2020
Figure 43. APAC Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 44. APAC Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 45. China Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 52. Europe Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 53. Europe Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 54. Europe Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 55. Germany Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 64. Egypt Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
